Zoekresultaten - 4 results
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study
Viruses, Volume 14, Issue 5 (2022) Keywords: SARS-CoV-2; COVID-19; antibodies; seroprevalence; cohort; population-based study; Belgium Abstract: The prevalence of anti- SARS-CoV-2 antibodies and potential ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
chronic diseases. Vaccinated people who were also vaccinated against influenza in 2020-2021 are more likely to have anti- SARS-CoV-2 antibodies than those who did not receive a flu vaccine. A hypothesis is that a flu ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
from the national influenza surveillance networks in Belgium during the winter seasons of 2015-20. Respiratory specimens were collected through the severe acute respiratory infection (SARI) and the ...
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
influenza to patients actively having the disease showed promising effects on mortality and appeared safe. Whether or not this also holds true for the novel SARS-CoV-2 virus is currently unknown. METHODS: DAW ...